Bioais reports positive results re multiple sclerosis
Bioais has reported positive results from an efficacy study of a blood-brain barrier penetrant interleukin-1 receptor inhibitor in a preclinical rodent model of multiple sclerosis....
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Bioais has reported positive results from an efficacy study of a blood-brain barrier penetrant interleukin-1 receptor inhibitor in a preclinical rodent model of multiple sclerosis....
Less than four years after a team of former Alexion Pharmaceuticals executives launched a startup to develop new therapies for severe and rare disorders, their...
InveniAI andi Sosei Group have announced a new R&D collaboration. The collaboration will combine InveniAI’s AI-powered platform, AlphaMeld®, for target discovery with Sosei Heptares’ G-protein...
A proposal authorizing $47 million in bond funds over five years for what UConn officials have termed “innovation faculty hires” was added to a bonding...
Bioasis, which is developing iproprietary platform technology for the delivery of therapeutics across the blood-brain barrier, has announced the appointment of Dave Jenkins as Chief Financial...
A proposal authorizing $47 million in bond funds over five years for what UConn officials have termed “innovation faculty hires” was added to a bonding...
Jacqueline Heard, founder and CEO of Enko, decided to move the company away from Boston to a 91,000-square-foot facility in Mystic, CT. “We don’t see any...
Bioasis Technologies has announced a research collaboration with Oxyrane UK Ltd. The collaboration will focus on combining the two companies’ platform technologies to deliver an undisclosed...
U.S. Senator Chris Murphy has named Intensity Therapeutics, based in Westport, June’s “Innovator of the Month.” Intensity Therapeutics is a clinical-stage biotechnology company focused on...
Vanessa Biotech has registered VR-AD-1005, a novel antidiarrheal investigational drug, with the Pan African Clinical Trials Registry system. The drug will be studied for the innovative...